Meeting of the Oncologic Drugs Advisory Committee (ODAC)

May 22, 2024 Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory CommitteeПодробнее

April 12, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)Подробнее

MRD as an endpoint for accelerating drug approval in multiple myeloma: updates from the ODAC meetingПодробнее

March 15, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)Подробнее

November 16, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)Подробнее

Ep. 56 - FDA’s ODAC Bind; plus NK Cell Engagers and Company Creation in EuropeПодробнее

March 14, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)Подробнее

Disappointing Sotorasib Results: How to Move ForwardПодробнее

Using MRD to accelerate drug approval in multiple myelomaПодробнее

Conversations on Cancer: ODAC Chronicles - Past, Present, & Future of Oncology Advisory CommitteesПодробнее

April 28, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)Подробнее

October 28, 2022 Meeting of the Oncologic Drugs Advisory Committee (ODAC)Подробнее

May 19, 2023 Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC)Подробнее

September 22-23, 2022 Meeting of the Oncologic Drugs Advisory Committee (ODAC) - Day 2Подробнее

Oncologic Drugs Advisory Committee MeetingПодробнее

September 22-23, 2022 Meeting of the Oncologic Drugs Advisory Committee (ODAC) - Day 1Подробнее

Clinical implications of the ODAC vote in favor of polatuzumab vedotin for untreated DLBCL.Подробнее

June 16, 2023 Meeting of the pedsODACПодробнее

March 9, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)Подробнее

February 9, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)Подробнее